• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下一阶段:分子流行病学。

The next stage: molecular epidemiology.

作者信息

Shpilberg O, Dorman J S, Ferrell R E, Trucco M, Shahar A, Kuller L H

机构信息

Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania 15261, USA.

出版信息

J Clin Epidemiol. 1997 Jun;50(6):633-8. doi: 10.1016/s0895-4356(97)00052-8.

DOI:10.1016/s0895-4356(97)00052-8
PMID:9250260
Abstract

The traditional approach in epidemiology of relating exposure to an environmental agent such as a drug or infective agent has been to measure an overall risk (i.e., average and then "adjust risk for demographic variables and other confounders"). An attempt is sometimes made to define a "susceptible" subgroup. The analyses are usually based on good statistical methodology rather than an understanding of the interaction of body of host and agent. A twofold risk for 1000 exposed versus nonexposed people could be an average twofold risk for all 1000 exposed or a 20-fold risk for 100 exposed individuals (i.e., a drug-host interaction). Clearly, finding the 100 individuals with a 20-fold risk has much greater clinical importance than a twofold risk for 1000 people. The world of epidemiology may be changing-we may soon be able to define risk based on genetic susceptibility, at least sometimes.

摘要

流行病学中传统的方法是将暴露于环境因素(如药物或感染因子)与疾病联系起来,即测量总体风险(即平均风险,然后“根据人口统计学变量和其他混杂因素调整风险”)。有时会尝试定义一个“易感”亚组。分析通常基于良好的统计方法,而非对宿主与因素之间相互作用的理解。对于1000名暴露者和未暴露者而言,两倍的风险可能意味着所有1000名暴露者的平均风险为两倍,或者100名暴露个体的风险为20倍(即药物与宿主的相互作用)。显然,找出风险为20倍的100名个体比1000人的两倍风险具有更大的临床意义。流行病学领域可能正在发生变化——至少在某些情况下,我们或许很快就能基于基因易感性来定义风险。

相似文献

1
The next stage: molecular epidemiology.下一阶段:分子流行病学。
J Clin Epidemiol. 1997 Jun;50(6):633-8. doi: 10.1016/s0895-4356(97)00052-8.
2
Oral contraceptives and thromboembolism: a reassessment.口服避孕药与血栓栓塞:重新评估
Am J Obstet Gynecol. 1975 Dec 15;123(8):878-914. doi: 10.1016/0002-9378(75)90866-2.
3
Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study.1型糖尿病肾病:胰岛素抵抗和多种遗传易感性的一种表现?来自匹兹堡糖尿病并发症流行病学研究的进一步证据。
Kidney Int. 2002 Sep;62(3):963-70. doi: 10.1046/j.1523-1755.2002.00507.x.
4
Oral contraceptives and venous thromboembolism.口服避孕药与静脉血栓栓塞症
N Z Med J. 2000 Sep 8;113(1117):385.
5
Epidemiology and risk factors of venous thromboembolism.静脉血栓栓塞症的流行病学及危险因素
Semin Thromb Hemost. 2006 Oct;32(7):651-8. doi: 10.1055/s-2006-951293.
6
Hormonal choices after gestational diabetes. Subsequent pregnancy, contraception, and hormone replacement.妊娠期糖尿病后的激素选择。后续妊娠、避孕及激素替代治疗。
Diabetes Care. 1998 Aug;21 Suppl 2:B50-7.
7
Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.凝血因子V莱顿突变与血栓栓塞性疾病风险:临床视角
Ann Intern Med. 1997 Nov 15;127(10):895-903. doi: 10.7326/0003-4819-127-10-199711150-00007.
8
Should we screen for factor V Leiden?我们应该筛查凝血因子V莱顿突变吗?
J Med Screen. 1998;5(1):1-2. doi: 10.1136/jms.5.1.1.
9
Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies.口服避孕药与心血管疾病:对流行病学研究的批判
Am J Obstet Gynecol. 1985 Jul 15;152(6 Pt 2):729-98. doi: 10.1016/s0002-9378(85)80001-6.
10
[Estrogen therapy and venous thromboembolic disease].[雌激素疗法与静脉血栓栓塞性疾病]
Rev Med Interne. 1997;18 Suppl 6:620s-625s. doi: 10.1016/s0248-8663(97)80708-4.

引用本文的文献

1
"Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities.21 世纪转化癌症流行病学的“驱动力”:需求与机遇。
Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):181-8. doi: 10.1158/1055-9965.EPI-12-1262. Epub 2013 Jan 15.
2
Molecular epidemiology of β-thalassemia in Pakistan: Far reaching implications.巴基斯坦β地中海贫血的分子流行病学:深远影响
Indian J Hum Genet. 2012 May;18(2):193-7. doi: 10.4103/0971-6866.100762.
3
Molecular epidemiology of β-thalassemia in Pakistan: far reaching implications.
巴基斯坦β地中海贫血的分子流行病学:影响深远
Int J Mol Epidemiol Genet. 2011;2(4):403-8. Epub 2011 Nov 28.
4
The evolving discipline of molecular epidemiology of cancer.癌症分子流行病学的发展。
Carcinogenesis. 2010 Jan;31(1):127-34. doi: 10.1093/carcin/bgp246. Epub 2009 Dec 18.
5
Genetic epidemiology and primary care.遗传流行病学与初级保健。
Br J Gen Pract. 2006 Mar;56(524):214-21.
6
Quantifying the advantages and disadvantages of pre-placement genetic screening.量化植入前基因筛查的利弊。
Occup Environ Med. 2004 May;61(5):448-53. doi: 10.1136/oem.2002.005611.